$1.92 Billion is the total value of Eventide Asset Management's 140 reported holdings in Q4 2017. The portfolio turnover from Q3 2017 to Q4 2017 was 20.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| XPO | Sell | XPO LOGISTICS INC | $72,173,000 | +20.5% | 788,000 | -10.9% | 3.76% | +10.8% |
| ASND | Buy | ASCENDIS PHARMA A Ssponsored adr | $53,382,000 | +22.3% | 1,332,540 | +10.6% | 2.78% | +12.4% |
| LOW | LOWES COS INC | $52,511,000 | +16.3% | 565,000 | 0.0% | 2.74% | +6.9% | |
| W | Buy | WAYFAIR INCcl a | $50,249,000 | +32.0% | 626,000 | +10.8% | 2.62% | +21.4% |
| BLUE | Sell | BLUEBIRD BIO INC | $49,441,000 | -12.6% | 277,603 | -32.6% | 2.58% | -19.6% |
| MIC | Buy | MACQUARIE INFRASTRUCTURE COR | $47,322,000 | -10.3% | 737,100 | +0.8% | 2.47% | -17.5% |
| AVXS | Buy | AVEXIS INC | $46,592,000 | +41.9% | 421,000 | +24.0% | 2.43% | +30.5% |
| AIMT | Buy | AIMMUNE THERAPEUTICS INC | $46,367,000 | +81.6% | 1,226,000 | +19.0% | 2.42% | +67.0% |
| ABBV | Sell | ABBVIE INC | $43,229,000 | -12.3% | 447,000 | -19.4% | 2.25% | -19.3% |
| LRCX | LAM RESEARCH CORP | $41,784,000 | -0.5% | 227,000 | 0.0% | 2.18% | -8.5% | |
| COLL | COLLEGIUM PHARMACEUTICAL INC | $40,752,000 | +76.0% | 2,207,610 | 0.0% | 2.12% | +61.9% | |
| STLD | STEEL DYNAMICS INC | $37,566,000 | +25.1% | 871,000 | 0.0% | 1.96% | +15.0% | |
| WBC | WABCO HLDGS INC | $36,679,000 | -3.0% | 255,600 | 0.0% | 1.91% | -10.8% | |
| WCN | Buy | WASTE CONNECTIONS INC | $36,676,000 | +24.8% | 517,000 | +23.1% | 1.91% | +14.8% |
| MGA | Buy | MAGNA INTL INC | $34,569,000 | +6.4% | 610,000 | +0.2% | 1.80% | -2.1% |
| CCI | Sell | CROWN CASTLE INTL CORP NEW | $33,858,000 | +10.3% | 305,000 | -0.7% | 1.76% | +1.4% |
| NEP | Sell | NEXTERA ENERGY PARTNERS LP | $33,738,000 | +5.7% | 782,600 | -1.2% | 1.76% | -2.8% |
| LEA | LEAR CORP | $32,505,000 | +2.1% | 184,000 | 0.0% | 1.69% | -6.1% | |
| TTD | Buy | THE TRADE DESK INC | $31,508,000 | -5.8% | 689,000 | +26.7% | 1.64% | -13.4% |
| KAR | Buy | KAR AUCTION SVCS INC | $30,811,000 | +11.9% | 610,000 | +5.7% | 1.61% | +2.9% |
| SAGE | Buy | SAGE THERAPEUTICS INC | $30,405,000 | +206.9% | 184,600 | +16.1% | 1.58% | +182.5% |
| STKL | Buy | SUNOPTA INC | $30,241,000 | -10.6% | 3,902,025 | +0.4% | 1.58% | -17.8% |
| ASML | ASML HOLDING N V | $29,897,000 | +1.5% | 172,000 | 0.0% | 1.56% | -6.6% | |
| SNA | Buy | SNAP ON INC | $28,649,000 | +17.6% | 164,365 | +0.5% | 1.49% | +8.1% |
| CELG | CELGENE CORP | $28,626,000 | -28.4% | 274,300 | 0.0% | 1.49% | -34.2% | |
| SGEN | SEATTLE GENETICS INC | $28,088,000 | -1.7% | 525,000 | 0.0% | 1.46% | -9.6% | |
| INST | INSTRUCTURE INC | $27,870,000 | -0.2% | 842,000 | 0.0% | 1.45% | -8.2% | |
| XLRN | ACCELERON PHARMA INC | $27,752,000 | +13.7% | 653,900 | 0.0% | 1.45% | +4.6% | |
| SPLK | SPLUNK INC | $27,420,000 | +24.7% | 331,000 | 0.0% | 1.43% | +14.7% | |
| VRTX | VERTEX PHARMACEUTICALS INC | $26,975,000 | -1.4% | 180,000 | 0.0% | 1.41% | -9.3% | |
| IDTI | INTEGRATED DEVICE TECHNOLOGY | $24,557,000 | +11.9% | 826,000 | 0.0% | 1.28% | +2.9% | |
| LOXO | LOXO ONCOLOGY INC | $23,991,000 | -8.6% | 285,000 | 0.0% | 1.25% | -15.9% | |
| ARW | ARROW ELECTRS INC | $23,721,000 | 0.0% | 295,000 | 0.0% | 1.24% | -8.0% | |
| CAFD | Buy | 8POINT3 ENERGY PARTNERS LPcl a rpt ltdpt | $22,228,000 | +1.4% | 1,461,400 | +0.2% | 1.16% | -6.7% |
| PEGI | Buy | PATTERN ENERGY GROUP INCcl a | $22,017,000 | +2.1% | 1,024,500 | +14.5% | 1.15% | -6.1% |
| ELLI | ELLIE MAE INC | $21,635,000 | +8.9% | 242,000 | 0.0% | 1.13% | +0.2% | |
| IPHI | INPHI CORP | $20,313,000 | -7.8% | 555,000 | 0.0% | 1.06% | -15.1% | |
| JELD | New | JELD-WEN HLDG INC | $19,941,000 | – | 506,500 | +100.0% | 1.04% | – |
| CRUS | CIRRUS LOGIC INC | $19,188,000 | -2.7% | 370,000 | 0.0% | 1.00% | -10.6% | |
| HUBS | HUBSPOT INC | $18,387,000 | +5.2% | 208,000 | 0.0% | 0.96% | -3.2% | |
| AY | Sell | ATLANTICA YIELD PLC | $17,085,000 | +7.3% | 805,500 | -0.3% | 0.89% | -1.2% |
| STML | STEMLINE THERAPEUTICS INC | $16,948,000 | +40.5% | 1,086,400 | 0.0% | 0.88% | +29.3% | |
| HASI | Sell | HANNON ARMSTRONG SUST INFR C | $16,775,000 | -2.4% | 697,200 | -1.1% | 0.87% | -10.3% |
| ONCE | SPARK THERAPEUTICS INC | $16,660,000 | -42.3% | 324,000 | 0.0% | 0.87% | -47.0% | |
| SAGE | New | SAGE THERAPEUTICS INCcall | $16,471,000 | – | 100,000 | +100.0% | 0.86% | – |
| LII | New | LENNOX INTL INC | $15,620,000 | – | 75,000 | +100.0% | 0.81% | – |
| WVE | WAVE LIFE SCIENCES LTD | $15,216,000 | +61.4% | 433,500 | 0.0% | 0.79% | +48.5% | |
| FIVN | FIVE9 INC | $14,331,000 | +4.1% | 576,000 | 0.0% | 0.75% | -4.2% | |
| VMC | VULCAN MATLS CO | $14,121,000 | +7.3% | 110,000 | 0.0% | 0.74% | -1.3% | |
| PFPT | PROOFPOINT INC | $14,032,000 | +1.8% | 158,000 | 0.0% | 0.73% | -6.4% | |
| VCYT | VERACYTE INC | $13,932,000 | -25.5% | 2,133,500 | 0.0% | 0.73% | -31.5% | |
| TWLO | Buy | TWILIO INCcl a | $13,570,000 | -0.5% | 575,000 | +25.8% | 0.71% | -8.5% |
| APTV | New | APTIV PLC | $13,403,000 | – | 158,000 | +100.0% | 0.70% | – |
| PANW | Buy | PALO ALTO NETWORKS INC | $13,045,000 | +30.5% | 90,000 | +29.7% | 0.68% | +19.9% |
| DOOR | Sell | MASONITE INTL CORP NEW | $12,606,000 | -19.0% | 170,000 | -24.4% | 0.66% | -25.5% |
| AGIO | AGIOS PHARMACEUTICALS INC | $12,234,000 | -14.4% | 214,000 | 0.0% | 0.64% | -21.2% | |
| NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $12,104,000 | +58.0% | 156,000 | +24.8% | 0.63% | +45.4% |
| VYGR | Buy | VOYAGER THERAPEUTICS INC | $11,677,000 | +1.0% | 703,425 | +25.3% | 0.61% | -7.0% |
| ALNY | ALNYLAM PHARMACEUTICALS INC | $11,435,000 | +8.1% | 90,000 | 0.0% | 0.60% | -0.5% | |
| BPMC | Sell | BLUEPRINT MEDICINES CORP | $11,312,000 | -31.2% | 150,000 | -36.4% | 0.59% | -36.7% |
| ACAD | ACADIA PHARMACEUTICALS INC | $10,078,000 | -20.1% | 334,700 | 0.0% | 0.52% | -26.6% | |
| TSLA | TESLA INC | $9,341,000 | -8.7% | 30,000 | 0.0% | 0.49% | -16.0% | |
| SRPT | SAREPTA THERAPEUTICS INC | $8,958,000 | +22.7% | 161,000 | 0.0% | 0.47% | +12.8% | |
| GWPH | GW PHARMACEUTICALS PLCads | $8,383,000 | +30.1% | 63,500 | 0.0% | 0.44% | +19.7% | |
| SNSS | Buy | SUNESIS PHARMACEUTICALS INC | $8,360,000 | +33340.0% | 2,265,455 | +17194.9% | 0.44% | +43500.0% |
| VRNS | New | VARONIS SYS INC | $8,156,000 | – | 168,000 | +100.0% | 0.42% | – |
| VBIV | New | VBI VACCINES INC | $7,900,000 | – | 1,850,000 | +100.0% | 0.41% | – |
| FENC | New | FENNEC PHARMACEUTICALS INC | $7,390,000 | – | 741,175 | +100.0% | 0.38% | – |
| AKCA | AKCEA THERAPEUTICS INC | $7,291,000 | -37.3% | 420,000 | 0.0% | 0.38% | -42.3% | |
| CERN | CERNER CORP | $7,292,000 | -5.5% | 108,200 | 0.0% | 0.38% | -13.0% | |
| EXR | EXTRA SPACE STORAGE INC | $7,171,000 | +9.4% | 82,000 | 0.0% | 0.37% | +0.8% | |
| BOLD | AUDENTES THERAPEUTICS INC | $7,031,000 | +11.6% | 225,000 | 0.0% | 0.37% | +2.8% | |
| MYOV | Buy | MYOVANT SCIENCES LTD | $6,979,000 | -18.0% | 552,100 | +0.4% | 0.36% | -24.5% |
| KALV | Buy | KALVISTA PHARMACEUTICALS INC | $6,913,000 | +162.2% | 709,000 | +79.0% | 0.36% | +141.6% |
| FPRX | Sell | FIVE PRIME THERAPEUTICS INC | $6,905,000 | -71.9% | 315,000 | -47.6% | 0.36% | -74.2% |
| XNCR | XENCOR INC | $6,861,000 | -4.4% | 313,000 | 0.0% | 0.36% | -12.0% | |
| ZGNX | New | ZOGENIX INC | $6,728,000 | – | 168,000 | +100.0% | 0.35% | – |
| BMRN | BIOMARIN PHARMACEUTICAL INC | $6,688,000 | -4.2% | 75,000 | 0.0% | 0.35% | -11.9% | |
| BHVN | Buy | BIOHAVEN PHARMACTL HLDG CO L | $6,529,000 | +228.1% | 242,000 | +354.5% | 0.34% | +200.9% |
| IFRX | New | INFLARX NV | $5,761,000 | – | 275,000 | +100.0% | 0.30% | – |
| PTGX | Buy | PROTAGONIST THERAPEUTICS INC | $5,720,000 | +158.9% | 275,000 | +120.0% | 0.30% | +138.4% |
| EXAS | EXACT SCIENCES CORP | $5,254,000 | +11.5% | 100,000 | 0.0% | 0.27% | +2.6% | |
| SUPN | SUPERNUS PHARMACEUTICALS INC | $5,181,000 | -0.4% | 130,000 | 0.0% | 0.27% | -8.5% | |
| ATHN | ATHENAHEALTH INC | $4,922,000 | +7.0% | 37,000 | 0.0% | 0.26% | -1.5% | |
| GLPG | GALAPAGOS NVspon adr | $4,876,000 | -7.8% | 52,000 | 0.0% | 0.25% | -15.3% | |
| MYOK | Buy | MYOKARDIA INC | $4,631,000 | +48.0% | 110,000 | +50.7% | 0.24% | +36.2% |
| PRTA | PROTHENA CORP PLC | $4,499,000 | -42.1% | 120,000 | 0.0% | 0.24% | -46.6% | |
| DBVT | DBV TECHNOLOGIES S Asponsored adr | $4,182,000 | -42.0% | 170,000 | 0.0% | 0.22% | -46.7% | |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | $4,054,000 | -12.9% | 87,400 | 0.0% | 0.21% | -20.1% | |
| RGEN | REPLIGEN CORP | $3,991,000 | -5.3% | 110,000 | 0.0% | 0.21% | -13.0% | |
| ACRS | ACLARIS THERAPEUTICS INC | $3,452,000 | -4.5% | 140,000 | 0.0% | 0.18% | -12.2% | |
| DERM | DERMIRA INC | $3,448,000 | +3.0% | 124,000 | 0.0% | 0.18% | -5.3% | |
| VICL | New | VICAL INC | $3,111,000 | – | 1,700,000 | +100.0% | 0.16% | – |
| TCON | TRACON PHARMACEUTICALS INC | $3,015,000 | +6.3% | 900,000 | 0.0% | 0.16% | -2.5% | |
| TTPH | TETRAPHASE PHARMACEUTICALS I | $2,921,000 | -7.9% | 463,700 | 0.0% | 0.15% | -15.6% | |
| IRWD | IRONWOOD PHARMACEUTICALS INC | $2,878,000 | -5.0% | 192,000 | 0.0% | 0.15% | -12.8% | |
| NTUS | NATUS MEDICAL INC DEL | $2,865,000 | +1.8% | 75,000 | 0.0% | 0.15% | -6.3% | |
| REGN | REGENERON PHARMACEUTICALS | $2,820,000 | -15.9% | 7,500 | 0.0% | 0.15% | -22.6% | |
| MGNX | MACROGENICS INC | $2,793,000 | +2.8% | 147,000 | 0.0% | 0.15% | -5.2% | |
| DLPH | New | DELPHI TECHNOLOGIES PLC | $2,763,000 | – | 52,666 | +100.0% | 0.14% | – |
| BEP | Buy | BROOKFIELD RENEWABLE PARTNERpartnership unit | $2,716,000 | +62.1% | 77,800 | +55.6% | 0.14% | +49.5% |
| INCY | Sell | INCYTE CORP | $2,557,000 | -45.2% | 27,000 | -32.5% | 0.13% | -49.8% |
| SEP | Buy | SPECTRA ENERGY PARTNERS LP | $2,471,000 | +11.4% | 62,500 | +25.0% | 0.13% | +2.4% |
| ACHN | ACHILLION PHARMACEUTICALS IN | $2,448,000 | -35.9% | 850,000 | 0.0% | 0.13% | -40.7% | |
| TSRO | TESARO INC | $2,155,000 | -35.8% | 26,000 | 0.0% | 0.11% | -41.1% | |
| FHB | Buy | FIRST HAWAIIAN INC | $2,133,000 | +34.2% | 73,100 | +39.2% | 0.11% | +23.3% |
| AQXP | AQUINOX PHARMACEUTICALS INC | $2,058,000 | -17.1% | 175,000 | 0.0% | 0.11% | -24.1% | |
| ABB | Sell | ABB LTDsponsored adr | $2,020,000 | +2.0% | 75,300 | -5.9% | 0.10% | -6.2% |
| JCI | Buy | JOHNSON CTLS INTL PLC | $2,001,000 | +8.0% | 52,500 | +14.1% | 0.10% | -1.0% |
| PBYI | PUMA BIOTECHNOLOGY INC | $1,977,000 | -17.5% | 20,000 | 0.0% | 0.10% | -24.3% | |
| GTTN | New | GTT COMMUNICATIONS INC | $1,983,000 | – | 42,246 | +100.0% | 0.10% | – |
| HMC | Buy | HONDA MOTOR LTD | $1,852,000 | +20.5% | 54,350 | +4.5% | 0.10% | +11.5% |
| EIGR | New | EIGER BIOPHARMACEUTICALS INC | $1,744,000 | – | 125,000 | +100.0% | 0.09% | – |
| TSM | Buy | TAIWAN SEMICONDUCTOR MFG LTDsponsored adr | $1,527,000 | +16.2% | 38,500 | +10.0% | 0.08% | +8.1% |
| PAYC | PAYCOM SOFTWARE INC | $1,477,000 | +7.2% | 18,382 | 0.0% | 0.08% | -1.3% | |
| BDN | Buy | BRANDYWINE RLTY TRsh ben int new | $1,482,000 | +7.2% | 81,500 | +3.2% | 0.08% | -1.3% |
| SYRS | SYROS PHARMACEUTICALS INC | $1,460,000 | -33.9% | 150,000 | 0.0% | 0.08% | -39.2% | |
| BCRX | BIOCRYST PHARMACEUTICALS | $1,424,000 | -6.3% | 290,000 | 0.0% | 0.07% | -14.0% | |
| HANNON ARMSTRONG SUST INFR Cnote | $1,289,000 | -0.6% | 1,250,000 | 0.0% | 0.07% | -9.5% | ||
| MLHR | New | MILLER HERMAN INC | $1,270,000 | – | 31,700 | +100.0% | 0.07% | – |
| BG | Buy | BUNGE LIMITED | $1,228,000 | +30.9% | 18,300 | +35.6% | 0.06% | +20.8% |
| TERP | Buy | TERRAFORM PWR INC | $1,235,000 | +78.0% | 103,300 | +96.8% | 0.06% | +64.1% |
| CDTX | Sell | CIDARA THERAPEUTICS INC | $1,170,000 | -45.3% | 172,000 | -34.8% | 0.06% | -49.6% |
| APU | Buy | AMERIGAS PARTNERS L Punit l p int | $1,156,000 | +5.0% | 25,000 | +2.0% | 0.06% | -3.2% |
| CMTA | CLEMENTIA PHARMACEUTICALS IN | $1,139,000 | +12.4% | 60,000 | 0.0% | 0.06% | +3.5% | |
| PTCT | PTC THERAPEUTICS INC | $1,138,000 | -16.6% | 68,200 | 0.0% | 0.06% | -23.4% | |
| ETN | Buy | EATON CORP PLC | $1,003,000 | +24.4% | 12,700 | +21.0% | 0.05% | +13.0% |
| CCIPRA | Buy | CROWN CASTLE INTL CORP NEW6.875% con pfd a | $852,000 | +32.9% | 755 | +25.8% | 0.04% | +22.2% |
| WBK | Buy | WESTPAC BKG CORPsponsored adr | $831,000 | +1.3% | 34,100 | +4.9% | 0.04% | -6.5% |
| CVA | New | COVANTA HLDG CORP | $688,000 | – | 40,700 | +100.0% | 0.04% | – |
| ERIC | Sell | ERICSSONadr b sek 10 | $635,000 | +5.1% | 95,000 | -9.5% | 0.03% | -2.9% |
| CIG | New | COMPANHIA ENERGETICA DE MINAsp adr n-v pfd | $608,000 | – | 295,000 | +100.0% | 0.03% | – |
| VTR | Buy | VENTAS INC | $594,000 | +30.3% | 9,900 | +41.4% | 0.03% | +19.2% |
| NYLD | Sell | NRG YIELD INCcl c | $592,000 | -56.8% | 31,300 | -55.9% | 0.03% | -60.3% |
| AYI | Buy | ACUITY BRANDS INC | $581,000 | +69.4% | 3,300 | +65.0% | 0.03% | +57.9% |
| ESSA PHARMA INC | $576,000 | -17.6% | 2,719,410 | 0.0% | 0.03% | -25.0% | ||
| WELL | Buy | WELLTOWER INC | $564,000 | +45.7% | 8,850 | +60.9% | 0.03% | +31.8% |
| LXP | LEXINGTON REALTY TRUST | $531,000 | -5.5% | 55,000 | 0.0% | 0.03% | -12.5% | |
| LPT | LIBERTY PPTY TRsh ben int | $516,000 | +4.7% | 12,000 | 0.0% | 0.03% | -3.6% | |
| ACORDA THERAPEUTICS INCnote | $341,000 | -6.1% | 400,000 | 0.0% | 0.02% | -14.3% | ||
| GLBL | Exit | TERRAFORM GLOBAL INCcl a | $0 | – | -160,000 | -100.0% | -0.04% | – |
| KALA | Exit | KALA PHARMACEUTICALS INC | $0 | – | -60,000 | -100.0% | -0.08% | – |
| RARX | Exit | RA PHARMACEUTICALS INC | $0 | – | -100,000 | -100.0% | -0.08% | – |
| CHRS | Exit | COHERUS BIOSCIENCES INC | $0 | – | -145,000 | -100.0% | -0.11% | – |
| DRNA | Exit | DICERNA PHARMACEUTICALS INC | $0 | – | -377,000 | -100.0% | -0.12% | – |
| SNDX | Exit | SYNDAX PHARMACEUTICALS INC | $0 | – | -225,000 | -100.0% | -0.15% | – |
| ATRC | Exit | ATRICURE INC | $0 | – | -180,000 | -100.0% | -0.23% | – |
| RXDX | Exit | IGNYTA INC | $0 | – | -344,000 | -100.0% | -0.24% | – |
| EPZM | Exit | EPIZYME INC | $0 | – | -275,000 | -100.0% | -0.30% | – |
| GBT | Exit | GLOBAL BLOOD THERAPEUTICS IN | $0 | – | -190,000 | -100.0% | -0.33% | – |
| CYBR | Exit | CYBERARK SOFTWARE LTD | $0 | – | -342,000 | -100.0% | -0.80% | – |
| 3106PS | Exit | DELPHI AUTOMOTIVE PLC | $0 | – | -158,000 | -100.0% | -0.88% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-02-14
About Eventide Asset Management
Eventide Asset Management is a Boston-based investment firm that specializes in providing investment solutions to investors who are looking for long-term growth opportunities. The company was founded in 2008 by a group of experienced investment professionals who shared a common vision of creating a firm that would focus on investing in companies that are making a positive impact on society.
The company's investment philosophy is based on the belief that companies that are making a positive impact on society are more likely to be successful in the long run. Eventide's investment team conducts extensive research to identify companies that are aligned with this philosophy and have the potential to deliver strong returns over the long term.
The company's investment strategies are managed by a team of experienced professionals, including CEO Robin John, COO Finny Kuruvilla, and Chief Investment Officer, Dr. Finny Kuruvilla. The team has a proven track record of delivering strong returns to investors, and their investment strategies have been recognized by industry experts.
Eventide Asset Management offers a range of investment solutions, including mutual funds, separately managed accounts, and exchange-traded funds (ETFs). The company's funds are available to individual investors, financial advisors, and institutional investors.
Overall, Eventide Asset Management is a reputable investment firm that has a strong focus on investing in companies that are making a positive impact on society. The company's experienced investment team and proven track record make it a compelling option for investors who are looking for long-term growth opportunities.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| LOWES COS INC | 40 | Q3 2023 | 3.2% |
| PALO ALTO NETWORKS INC | 40 | Q3 2023 | 3.6% |
| ASML HOLDINGS NV | 40 | Q3 2023 | 1.9% |
| NEUROCRINE BIOSCIENCES INC | 40 | Q3 2023 | 1.1% |
| REPLIGEN CORP | 40 | Q3 2023 | 0.5% |
| VERACYTE INC | 38 | Q3 2023 | 1.5% |
| LAM RESEARCH CORP | 35 | Q3 2023 | 3.4% |
| XPO LOGISTICS INC | 34 | Q1 2023 | 3.8% |
| COLLEGIUM PHARMACEUTICAL INC | 34 | Q3 2023 | 2.6% |
| MAGNA INTL INC | 33 | Q4 2021 | 2.5% |
View Eventide Asset Management's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cogent Biosciences, Inc. | February 14, 2023 | 2,589,778 | 3.7% |
| ESSA Pharma Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Freeline Therapeutics Holdings plc | February 14, 2023 | 5,920,765 | 9.1% |
| KnowBe4, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Praxis Precision Medicines, Inc. | February 14, 2023 | 3,518,062 | 7.5% |
| Prometheus Biosciences, Inc. | February 14, 2023 | 1,032,938 | 2.2% |
| SUTRO BIOPHARMA, INC.Sold out | February 14, 2023 | 0 | 0.0% |
| Vital Farms, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Zymeworks Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Entasis Therapeutics Holdings Inc. | February 14, 2022 | 590,602 | 1.2% |
View Eventide Asset Management's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR/A | 2024-02-20 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View Eventide Asset Management's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.